Total Payments
$5,789
2024 Payments
$1,581
Companies
25
Transactions
230
Medicare Patients
1,522
Medicare Billing
$131,825
Payment Breakdown by Category
Food & Beverage$5,221 (90.2%)
Education$317.48 (5.5%)
Consulting$250.00 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,221 | 225 | 90.2% |
| Education | $317.48 | 4 | 5.5% |
| Consulting Fee | $250.00 | 1 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $945.46 | 44 | $0 (2024) |
| Incyte Corporation | $578.15 | 21 | $0 (2024) |
| Dermavant Sciences, Inc. | $467.23 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $403.36 | 10 | $0 (2024) |
| Lilly USA, LLC | $380.93 | 26 | $0 (2024) |
| Amgen Inc. | $341.16 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $327.05 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $300.57 | 10 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $253.52 | 9 | $0 (2024) |
| Medimetriks Pharmaceuticals, Inc. | $250.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,581 | 64 | Dermavant Sciences, Inc. ($317.58) |
| 2023 | $1,759 | 74 | GENZYME CORPORATION ($241.07) |
| 2022 | $1,635 | 55 | ABBVIE INC. ($515.33) |
| 2021 | $813.36 | 37 | Incyte Corporation ($182.90) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.80 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Dermatology | ||||||
| 11/27/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.82 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $23.70 | General |
| 10/28/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $12.62 | General |
| Category: DERMATOLOGY | ||||||
| 10/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.30 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: Dermatology | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Dermatology | ||||||
| 09/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: DERMATOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Dermatology | ||||||
| 09/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 09/06/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.38 | General |
| Category: Dermatology | ||||||
| 08/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $137.50 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 599 | 980 | $217,860 | $53,015 |
| 2022 | 10 | 378 | 667 | $134,140 | $34,946 |
| 2021 | 10 | 325 | 577 | $106,225 | $27,326 |
| 2020 | 6 | 220 | 378 | $71,950 | $16,538 |
Total Patients
1,522
Total Services
2,602
Medicare Billing
$131,825
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 167 | 299 | $58,305 | $20,178 | 34.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 92 | 117 | $40,950 | $9,030 | 22.1% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 20 | 23 | $23,230 | $4,676 | 20.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 62 | 93 | $27,900 | $3,918 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 42 | $9,450 | $3,854 | 40.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $7,750 | $2,535 | 32.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 44 | 54 | $8,100 | $2,263 | 27.9% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 23 | $11,500 | $1,549 | 13.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 13 | 18 | $9,000 | $1,528 | 17.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 27 | 35 | $6,125 | $1,434 | 23.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 24 | 28 | $6,300 | $1,071 | 17.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 44 | 177 | $8,850 | $943.53 | 10.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 40 | $400.00 | $33.95 | 8.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 216 | $42,120 | $14,883 | 35.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 59 | 70 | $24,500 | $5,517 | 22.5% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2022 | 13 | 17 | $17,170 | $3,826 | 22.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 52 | 73 | $21,900 | $3,434 | 15.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $5,750 | $1,915 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 16 | $3,600 | $1,532 | 42.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 25 | 36 | $6,300 | $1,528 | 24.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 30 | $4,500 | $1,398 | 31.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 36 | 161 | $8,050 | $889.27 | 11.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 12 | 25 | $250.00 | $23.24 | 9.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 100 | 178 | $35,340 | $12,301 | 34.8% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 52 | 69 | $24,150 | $5,559 | 23.0% |
About Lisa Sandler, PA
Lisa Sandler, PA is a Physician Assistant healthcare provider based in Deer Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1831352244.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lisa Sandler, PA has received a total of $5,789 in payments from pharmaceutical and medical device companies, with $1,581 received in 2024. These payments were reported across 230 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,221).
As a Medicare-enrolled provider, Sandler has provided services to 1,522 Medicare beneficiaries, totaling 2,602 services with total Medicare billing of $131,825. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Deer Park, NY
- Active Since 07/07/2008
- Last Updated 12/19/2014
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1831352244
Products in Payments
- SKYRIZI (Biological) $704.35
- OPZELURA (Drug) $578.15
- VTAMA (Drug) $467.23
- DUPIXENT (Biological) $399.80
- TALTZ (Drug) $353.43
- Otezla (Drug) $341.16
- TREMFYA (Drug) $328.91
- Sotyktu (Drug) $327.05
- Clindacin ETZ (Drug) $250.00
- RINVOQ (Biological) $210.92
- Zoryve (Drug) $183.36
- AMELUZ (Drug) $162.62
- LITFULO (Drug) $113.05
- Seysara (Drug) $109.05
- COSENTYX (Biological) $106.69
- Absorica LD (Drug) $98.31
- Winlevi (Drug) $90.94
- REMICADE (Biological) $74.45
- EUCRISA (Drug) $56.67
- COSENTYX (Drug) $55.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Deer Park
Ruben Saavedra, Pa-C, PA-C
Physician Assistant — Payments: $20,351
Physician Assistant $20,351
Brenda Wilks, Pa-C, PA-C
Physician Assistant — Payments: $8,590
Physician Assistant $8,590
David Moisan, Pa, PA
Physician Assistant — Payments: $1,900
Physician Assistant $1,900
Kendahl Ludiker, Pa, PA
Physician Assistant — Payments: $1,863
Physician Assistant $1,863
Blia Thao, Pa-C, PA-C
Physician Assistant — Payments: $830.19
Physician Assistant $830.19
Lauren Russo
Physician Assistant — Payments: $822.46
Physician Assistant $822.46